Increased IGF-I:IGFBP-3 ratio in patients with hepatocellular carcinoma

Clinical Endocrinology

Volumn 59, Issue 6, 2003, Pages 699-706

  Mattera, Daniele ^a   Capuano, Gaetano ^a   Colao, Annamaria ^a   Pivonello, Rosario ^a   Manguso, Francesco ^a   Puzziello, Alessandro ^a   D'Agostino, Luciano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION;

ADULT; AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0344944673     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01909.x     Document Type: Article

References (38)

1. Arany, E., Afford, S., Strain, A.J., Winwood, P.J., Arthur, M.J. & Hill, D.J. (1994) Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. Journal of Clinical Endocrinology and Metabolism, 79, 1871-1876.
2. Baserga, R., Prisco, M. & Hongo, A. (1999) IGFs and cell growth. In: The IGF System Molecular Biology, Physiology, and Clinical Applications (eds C.T. Roberts & R.G. Rosenfeld), pp. 329-353. Humana Press, Totowa, NJ.
3. Blanc, P., Desprez, D., Fabre, J.M., Pageaux, G., Daures, J.P., Larrey, D., Saint-Aubert, B., Michel, H. & Maurel, P. (1996) Contribution of primary cultures of adult human hepatocytes to the pathophysiology of hepatocellular carcinoma. Journal of Hepatology, 25, 663-669.
4. Burr, A.W., Hillan, K.J., McLaughlin, K.E., Ferrier, R., Chapman, C., Mathew, J. & Burt, A.D. (1996) Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology, 24, 1282-1287.
5. Buzzelli, G., Dattolo, P., Pinzani, M., Brocchi, A., Romano, S. & Gentilini, P. (1993) Circulating growth hormone and insulin-like growth factor 1 in nonalcoholic liver cirrhosis with or without super-imposed hepatocarcinoma: evidence of an altered circadian rhythm. American Journal of Gastroenterology, 88, 1744-1748.
6. Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H. & Pollak, M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279, 563-566.
7. Child, T.C. & Turcotte, J.G. (1964) Surgery in Portal Hypertension. WB Saunders, Philadelphia.
8. Chuang, L.M., Tai, T.Y., Kahn, R.C., Wu, H.P., Lee, S.C. & Lin, B.J. (1996) Signal transduction pathways for interleukin 4 and insulin in human hepatoma cells. Journal of Biochemistry Tokio, 120, 111-116.
9. Colao, A., Marzullo, P., Ferone, D., Spiezia, S., Cerbone, G., Marino, V., Di Sarno, A., Merla, B. & Lombardi, G. (1998) Prostatic hyperplasia: an unknown feature of acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 775-779.
10. D'Arienzo, A., Manguso, F., Scaglione, G., Vicinanza, G., Bennato, R. & Mazzacca, G. (1998) Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scandinavian Journal of Gastroenterology, 33, 1213-1218.
11. Donaghy, A., Ross, R., Gimson, A., Hughes, S.C., Holly, J. & Williams, R. (1995) Growth hormone, insulin-like growth factor I and insulin-like growth factor binding protein 1 and 3 in chronic liver disease. Hepatology, 21, 680-688.
12. Edmondson, H.A. & Steiner, P.E. (1954) Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies. Cancer, 7, 462-503.
13. Giovannucci, E., Pollak, M., Platz, E.A., Willett, W.C., Stampfer, M.J., Majeed, N., Colditz, G.A., Speizer, F.E. & Hankinson, S.E. (2000) Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study. Growth Hormone and IGF Research Supplement, A, S30-S31.
14. Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., Taniyama, M., Nakamura, S., Uemura, M., Takuma, Y., Yumoto, E., Higashi, T. & Tsuji, T. (2002) Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Letters, 176, 149-158.
15. Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E. & Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393-1396.
16. Huff, K.K., Kaufman, D., Gabbay, K.H., Spencer, E.M., Lippman, M.E. & Dichson, R.B. (1986) Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Research, 46, 4613-4619.
17. Jones, J.I. & Clemmonds, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Review, 16, 3-34.
18. Khandwala, H.M., McCutcheon, I.E., Flyvbjerg, A. & Friend, K.E. (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Review, 21, 215-244.
19. Kim, S.O., Park, J.G. & Lee, Y.I. (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor activation by hepatitis B X gene product. Cancer Research, 56, 3831-3836.
20. Ma, J., Pollak, M.N., Giovannucci, E., Chan, J.M., Tao, Y., Hennekens, C.H. & Stampfer, M.J. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Journal of National Cancer Institute, 91, 620-625.
21. Nakanishi, Y., Mulshine, J.L., Kasprzyk, P.G., Natale, R.B., Maneckjee, R., Avis, I., Treston, A.M., Gazdar, A.F., Minna, J.D. & Cuttitta, F. (1988) Insulin-like growth factor I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. Journal of Clinical Investigation, 82, 354-359.
22. Nardone, G., Romano, M., Calabro, A., Pedone, P.V., De Sio, I., Persico, M., Budillon, G., Bruni, C.B., Riccio, A. & Zarrilli, R. (1996) Activation of fetal promoters of insulin-like growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatology, 23, 1304-1312.
23. Ogasawara, S., Yano, H., Iemura, A., Hisaka, T. & Kojiro, M. (1996) Expression of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. Hepatology, 24, 198-205.
24. Oscarsson, J., Johannsson, G., Johansson, J.O., Lundberg, P.A., Lindstedt, G. & Bengtsson, B.A. (1997) Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults. Clinical Endocrinology, 46, 63-68.
25. Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. & Williams, R. (1973) Transections of the oesophagus for bleeding varices. British Journal of Surgery, 69, 449-451.
26. Shirai, Y., Kawata, S., Tamura, S., Ito, N., Tsushima, M., Takaishi, K., Kiso, S. & Matsuzawa, Y. (1994) Plasma transforming factor betal in patients with hepatocellular carcinoma. Cancer, 73, 2275-2279.
27. Sohda, T., Yun, K., Iwata, K., Soejima, H. & Okumura, M. (1996) Increased expression of insulin-like growth factor II in hepatocellular carcinoma is primarily regulated at transcriptional level. Laboratory Investigation, 75, 307-311.
28. Stuver, S.O., Kuper, H., Tzonou, A., Lagiou, P., Spanos, E., Hsieh, C.C., Mantzoros, C. & Trichopoulos, D. (2000) Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. International Journal of Cancer, 87, 118-121.
29. Su, T.S., Liu, W.Y, Han, S.H., Jansen, M., Yang-Fen, T.L., P'eng, F.K. & Chou, C.K. (1989) Transcripts of insulin-like growth factor-I and II in human hepatoma. Cancer Research, 49, 1773-1777.
30. 1-induced apoptosis. Cancer Research, 56, 3391-3394.
31. Tanaka, S. & Wands, J.R. (1996b) A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. Journal of Clinical Investigation, 98, 2100-2108.
32. Tanaka, S., Ito, T. & Wands, J.R. (1996) Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signalling molecules. Journal of Biological Chemistry, 27, 14610-14616.
33. Tomiya, T. & Fujiwara, K. (1996) Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis. Cancer, 77, 1056-1060.
34. Tricoli, J.V., Rall, L.B., Karakousis, C.P., Herrera, L., Petrelli, N.J., Bell, G.I. & Shows, T.B. (1986) Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Research, 46, 6169-6173.
35. Tsai, T.F., Yauk, Y.K., Chou, C.K., Ting, L.P., Chang, C., Hu, C.P., Han, S.H. & Su, T.S. (1988) Evidence of autocrine regulation in human hepatoma cell lines. Biochemical and Biophysical Research Communications, 153, 39-45.
36. Ueda, K. & Ganem, D. (1996) Apoptosis was induced by N-myc expression in hepatocyte, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. Journal of Virology, 70, 1375-1383.
37. Yang, D., Faris, R., Hixson, D., Affigne, S. & Rogler, C.E. (1996) Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells. Journal of Virology, 70, 6260-6268.
38. Yee, D., Paik, S., Lebovic, G.S., Marus, R.R., Favoni, R.E., Cullen, K.J., Lippman, M.E. & Rosen, N. (1989) Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Molecular Endocrinology, 3, 509-517.